Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of acute acoustic trauma with hyperbaric oxygen and medication in conscripts
2008-000444-13Phase 4Terminated
- Sponsor
- Finnish Defence Forces
- Start
- Mar 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of methylprednisolone and betahistine in noise-induced hearing loss (NIHL), barotrauma and tinnitus (2 arms), sponsored by Finnish Defence Forces. Primary endpoint: Audiometric investigation at 2 months. Started Mar 2008; status: terminated.
02
Drugs
methylprednisolonebetahistine
03
Conditions
noise-induced hearing loss (NIHL)barotraumatinnitus
Beyond the preview
Go deeper on 2008-000444-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000444-13.